PACAP attenuates NMDA-induced retinal damage in association with modulation of the microglia/macrophage status into an acquired deactivation subtype

Journal of Molecular Neuroscience

Volumn 51, Issue 2, 2013, Pages 493-502

  Wada, Yoshihiro ^a   Nakamachi, Tomoya ^a   Endo, Kimi ^a   Seki, Tamotsu ^a   Ohtaki, Hirokazu ^a   Tsuchikawa, Daisuke ^a   Hori, Motohide ^a   Tsuchida, Masashi ^a   Yoshikawa, Akira ^a   Matkovits, Attila ^a,b   Kagami, Nobuyuki ^a   Imai, Nori ^a   Fujisaka, Shiho ^c   Usui, Isao ^c   Tobe, Kazuyuki ^c   Koide, Ryohei ^a   Takahashi, Haruo ^a   Shioda, Seiji ^a  

^a SHOWA UNIVERSITY   (Japan)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Glaucoma; Microglia macrophage; Neurotrophic factor; NMDA; PACAP; Retinoprotection

Indexed keywords

BIOLOGICAL MARKER; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 10; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL INFILTRATION; CELL LOSS; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOMODULATION; IMMUNOREACTIVITY; MACROPHAGE; MALE; MICROGLIA; MOUSE; NONHUMAN; RETINA INJURY; TREATMENT OUTCOME; WILD TYPE;

MUS;

ANIMALS; CELL PROLIFERATION; GLAUCOMA; INTERLEUKIN-10; INTRAVITREAL INJECTIONS; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICROGLIA; N-METHYLASPARTATE; NEUROPROTECTIVE AGENTS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RETINA; RETINAL GANGLION CELLS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84885175290     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-0017-5     Document Type: Article

References (53)

1. Arimura A, Shioda S (1995) Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front Neuroendocrinol 16:53-88
2. Arimura A, Somogyvari-Vigh A, Miyata A, Mizuno K, Coy DH, Kitada C (1991) Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology 129:2787-9
3. Atlasz T, Szabadfi K, Kiss P et al (2011) Effects of PACAP in UV-A radiation-induced retinal degeneration models in rats. J Mol Neurosci 43:51-7
4. Bethea JR, Nagashima H, Acosta MC et al (1999) Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats. J Neurotrauma 16:851-63
5. Boyd ZS, Kriatchko A, Yang J, Agarwal N, Wax MB, Patil RV (2003) Interleukin-10 receptor signaling through STAT-3 regulates the apoptosis of retinal ganglion cells in response to stress. Invest Ophthalmol Vis Sci 44:5206-11
6. Brewer KL, Bethea JR, Yezierski RP (1999) Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Exp Neurol 159:484-93
7. Colton CA (2009) Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 4:399-418
8. Deckert-Schluter M, Buck C, Weiner D et al (1997) Interleukin-10 downregulates the intracerebral immune response in chronic Toxoplasma encephalitis. J Neuroimmunol 76:167-76
9. Delgado M, Ganea D (2001) Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in vitro and in vivo. J Immunol 167:966-75
10. Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D (1999) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. J Immunol 162:1707-16
11. Delgado M, Abad C, Martinez C et al (2003a) PACAP in immunity and inflammation. Ann N Y Acad Sci 992:141-57
12. Delgado M, Leceta J, Ganea D (2003b) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia. J Leukoc Biol 73:155-64
13. Dhandapani KM, Brann DW (2003) Transforming growth factor-beta: a neuroprotective factor in cerebral ischemia. Cell Biochem Biophys 39:13-22
14. Dkhissi O, Chanut E, Wasowicz M et al (1999) Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder. Invest Ophthalmol Vis Sci 40:990-5
15. Dobolyi A, Vincze C, Pal G, Lovas G (2012) The neuroprotective functions of transforming growth factor Beta proteins. Int J Mol Sci 13:8219-58
16. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA (1996) Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 114:299-305
17. Endo K, Nakamachi T, Seki T et al (2011) Neuroprotective effect of PACAP against NMDA-induced retinal damage in the mouse. J Mol Neurosci 43:22-9
18. Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953-64
19. Harmar AJ, Fahrenkrug J, Gozes I et al (2012) Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol 166:4-17
20. Huettner C, Czub S, Kerkau S, Roggendorf W, Tonn JC (1997) Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. Anticancer Res 17:3217-24
21. Jander S, Pohl J, D'Urso D, Gillen C, Stoll G (1998) Time course and cellular localization of interleukin-10 mRNA and protein expression in autoimmune inflammation of the rat central nervous system. Am J Pathol 152:975-82
22. Karlstetter M, Ebert S, Langmann T (2010) Microglia in the healthy and degenerating retina: insights from novel mouse models. Immunobiology 215:685-91
23. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A (2011) Physiology of microglia. Physiol Rev 91:461-553
24. Koeberle PD, Gauldie J, Ball AK (2004) Effects of adenoviral-mediated gene transfer of interleukin-10, interleukin-4, and transforming growth factor-beta on the survival of axotomized retinal ganglion cells. Neuroscience 125:903-20
25. Langmann T (2007) Microglia activation in retinal degeneration. J Leukoc Biol 81:1345-51
26. Lee WR, Grierson I (1977) Macrophage infiltration in the human retina. Albrecht Von Graefes Arch Klin Exp Ophthalmol 203:293-309
27. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25:677-86
28. Martinez FO, Sica A, Mantovani A, Locati M (2008) Macrophage activation and polarization. Front Biosci 13:453-61
29. Miyata A, Arimura A, Dahl RR et al (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567-74
30. Miyata A, Jiang L, Dahl RD et al (1990) Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170:643-8
31. Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958-69
32. Nakamachi T, Tsuchida M, Kagami N et al (2012) IL-6 and PACAP receptor expression and localization after global brain ischemia in mice. J Mol Neurosci 48:518-25
33. Novelli A, Reilly JA, Lysko PG, Henneberry RC (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res 451:205-12
34. Ohtaki H, Nakamachi T, Dohi K, Shioda S (2008) Role of PACAP in ischemic neural death. J Mol Neurosci 36:16-25
35. Reglodi D, Kiss P, Lubics A, Tamas A (2011) Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Curr Pharm Des 17:962-72
36. Schwartz M (2003) Macrophages and microglia in central nervous system injury: are they helpful or harmful? J Cereb Blood Flow Metab 23:385-94
37. Seki T, Shioda S, Ogino D, Nakai Y, Arimura A, Koide R (1997) Distribution and ultrastructural localization of a receptor for pituitary adenylate cyclase activating polypeptide and its mRNA in the rat retina. Neurosci Lett 238(3):127-30
38. Seki T, Nakatani M, Taki C et al (2006) Neuroprotective effect of PACAP against kainic acid-induced neurotoxicity in rat retina. Ann N Y Acad Sci 1070:531-4
39. Seki T, Itoh H, Nakamachi T, Shioda S (2008) Suppression of ganglion cell death by PACAP following optic nerve transection in the rat. J Mol Neurosci 36:57-60
40. Seki T, Itoh H, Nakamachi T et al (2011) Suppression of rat retinal ganglion cell death by PACAP following transient ischemia induced by high intraocular pressure. J Mol Neurosci 43:30-4
41. Sharma S, Yang B, Xi X, Grotta JC, Aronowski J, Savitz SI (2011) IL-10 directly protects cortical neurons by activating PI-3 kinase and STAT-3 pathways. Brain Res 1373:189-94
42. Somogyvari-Vigh A, Reglodi D (2004) Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr Pharm Des 10:2861-89
43. Spera PA, Ellison JA, Feuerstein GZ, Barone FC (1998) IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 251:189-92
44. Stoll G, Jander S (1999) The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol 58:233-47
45. Strle K, Zhou JH, Shen WH et al (2001) Interleukin-10 in the brain. Crit Rev Immunol 21:427-49
46. Sucher NJ, Aizenman E, Lipton SA (1991) N-methyl-D-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro. J Neurosci 11:966-71
47. Szabadfi K, Atlasz T, Kiss P et al (2012) Protective effects of the neuropeptide PACAP in diabetic retinopathy. Cell Tissue Res 348:37-46
48. Thanos S, Mey J, Wild M (1993) Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J Neurosci 13:455-66
49. Vaudry D, Falluel-Morel A, Bourgault S et al (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283-357
50. Vitkovic L, Maeda S, Sternberg E (2001) Anti-inflammatory cytokines: expression and action in the brain. Neuroimmunomodulation 9:295-312
51. Vrabec F (1975) Activated human retinal microglia under pathological conditions. Albrecht Von Graefes Arch Klin Exp Ophthalmol 196:49-60
52. Walshe TE, Leach LL, D'Amore PA (2011) TGF-beta signaling is required for maintenance of retinal ganglion cell differentiation and survival. Neuroscience 189:123-31
53. Yang S, Yang J, Yang Z et al (2006) Pituitary adenylate cyclase-activating polypeptide (PACAP) 38 and PACAP4-6 are neuroprotective through inhibition of NADPH oxidase: potent regulators of microglia-mediated oxidative stress. J Pharmacol Exp Ther 319:595-603